All News
|
Research Feature
Joncita Todechine, a mother of four who lives on the Navajo Nation, knows all too well what can trigger asthma symptoms in her daughter Ashley. But she didn’t always. She recalls a time in 2013, living in Phoenix and attending medical assistant school, when she rushed her then-three-year-old to the Indian Medical Center. “She was really sick,”...
Showing 10 out of 1704 results
|
NHLBI in the Press
During the longest and largest obesity prevention study of its kind, young children and their families in poor communities made some achievable and sustainable behavioral changes, but the results were insufficient to prevent early childhood obesity, researchers say.
|
NHLBI in the Press
Pulmonary alveolar proteinosis (PAP) is a rare disease in which a type of protein builds up in the air sacs of the lungs, making breathing difficult.
|
NHLBI in the Press
Researchers are reporting development and testing of a new drug-delivery system that allows rapid response to heart attacks without surgical intervention.
|
NHLBI in the Press
Researchers are reporting development of a potential new class of drugs that may reduce cardiovascular risk by targeting microbes in the gut.
|
NHLBI in the Press
The airways of the lung are the primary sites of major diseases, including asthma, chronic obstructive pulmonary disease and cystic fibrosis.
|
NHLBI in the Press
Atrial fibrillation is the most common cardiac arrhythmia—a disorder that affects the heart rate or heart rhythm. A recent genome-wide association study of more than one million people substantially increased the number of genetic risk variants associated with atrial fibrillation.
|
NHLBI in the Press
Integrins are proteins linked to a potentially life-threatening condition called fibrosis, which is characterized by the overgrowth, hardening, or scarring of various tissues.
|
NHLBI in the Press
Researchers have developed a tissue-engineered scale model of the human left ventricle.
|
NHLBI in the Press
Small RNAs are short molecules that regulate gene activity and have been implicated in a wide range of diseases, including cancer, cardiovascular disease and stroke.
|
NHLBI in the Press
Induced pluripotent stem cells (iPSCs) hold great promise for personalized medicine. iPSCs are immature cells that can be turned into a wide range of specialized cell types in the body for various applications, such as disease modeling, drug development, and cell transplantation.